Author Question: A patient is hospitalized for severe depression. Of the medications listed below, the nurse can ... (Read 58 times)

jerry coleman

  • Hero Member
  • *****
  • Posts: 570
A patient is hospitalized for severe depression. Of the medications listed below, the nurse can expect to provide the patient with teaching about:
 
  a. chlordiazepoxide (Librium).
  b. clozapine (Clozaril).
  c. sertraline (Zoloft).
  d. tacrine (Cognex).

Question 2

A patient has fear as well as increased heart rate and blood pressure. The nurse suspects increased activity of which neurotransmitter?
 
  a. Gamma-aminobutyric acid (GABA)
  b. Norepinephrine
  c. Acetylcholine
  d. Histamine



canderson530

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

ANS: C
Sertraline (Zoloft) is an SSRI. This antidepressant blocks the reuptake of serotonin, with few anticholinergic and sedating side effects. Clozapine is an antipsychotic. Chlordiazepoxide is an anxiolytic. Tacrine treats Alzheimer's disease.

Answer to Question 2

ANS: B
Norepinephrine is the neurotransmitter associated with sympathetic nervous system stimulation, preparing the individual for fight or flight. GABA is a mediator of anxiety level. A high concentration of histamine is associated with an inflammatory response. A high concentration of acetylcholine is associated with parasympathetic nervous system stimulation.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

Street names for barbiturates include reds, red devils, yellow jackets, blue heavens, Christmas trees, and rainbows. They are commonly referred to as downers.

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

For a complete list of videos, visit our video library